Xiidra

Chemical Namelifitegrast
Dosage FormDrops (eye; 5%)
Drug ClassOphthalmic agents
SystemOcular
CompanyNovartis
Approval Year2016

Indication

  • To treat the signs and symptoms of dry eye disease.
Last updated on 10/13/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xiidra (lifitegrast) Prescribing Information 2019Novartis Pharmaceuticals Corporation, East Hanover, NJ